About the Journal

Focus and Scope

Cermin Dunia Kedokteran (CDK) Journal (e-ISSN: 2503-2720) is a scientific journal in the field of medicine that has been published since 1974 and is affiliated with PT Kalbe Farma Tbk. The CDK Journal aims to facilitate scientific publications and to enhance and disseminate knowledge in the fields of medicine, pharmacy, and public health in a comprehensive, evidence-based, and relevant manner, keeping pace with the latest scientific advancements. 

Based on Ministry of Education, Culture, Research, and Technology Decree No. 152/E/KPT/2023, CDK has been ranked SINTA 4, with a commitment to achieving high-quality standards equivalent to those of Reputable International Journals (JIB).

The journal’s focus encompasses the development of clinical medicine, pharmacy, and public health oriented toward evidence-based practice, healthcare service innovation, and the integration of health policies within local, national, and global contexts.

Areas and Scope:

  1. Evidence-based clinical and biomedical research.
  2. Pharmaceutical studies, drug development, and innovative therapies.
  3. Public health, epidemiology, and health policy.
  4. Systematic review and meta-analysis.
  5. Case report and evidence-based case report (EBCR).
  6. Integration of medical science with public policy and health governance.
  7. Strategic global health issues such as digital health, health resilience, and health service inclusivity.

IMPORTANT NOTICE*

Effective October 5th, 2026, CDK Journal is temporarily not accepting new Literature Review submissions. We will still accept research articles, systematic reviews, meta-analyses, and case reports.

Literature Review manuscripts that have already been submitted will continue to be processed through the editorial and peer-review process.

*This information is valid until further notice

Editorial Process

An editor will review submitted articles to ensure their suitability in terms of focus and scope, as well as adherence to the general writing guidelines of the Cermin Dunia Kedokteran journal, within a maximum period of 1 week. Each article that passes this stage will be checked for plagiarism using Turnitin. If there is minor plagiarism, the article must be revised; if there is severe plagiarism, it will be rejected.

Next, the article will undergo a peer review process. Revisions may be required and will be re-evaluated by the editor in charge after the author provides an adequate response. The article will be submitted to the editor-in-chief for further revision, and ultimately an editorial decision will be made.

Accepted articles will enter the article editing stage for spelling and grammar checking, standardization of the journal's internal writing style, correction of tables and figures, and improvement of overall writing quality. Revisions that are not completed at this stage will result in a delayed publication schedule. The document will then enter the layout stage of the production process. Before publication, the corresponding author will be sent publication schedule information and must provide final confirmation of approval.

In general, the article submission process at CDK is as follows:

1. Initial screening, including suitability with the journal's focus and scope and CDK writing guidelines, as well as the similarity index.

2. Once the article fulfills the criteria, it will enter the review process by the editorial team and reviewer.

At this stage, if necessary, the author can obtain a letter stating that the article is under review and planned for publication in the CDK journal (Please note that it takes at least 2 weeks after the manuscript is submitted to receive a manuscript acknowledgment letter due to the initial review process).

3. The editorial team will send feedback to the author. The author will revise the article according to the review results (this can be done several times according to the editorial team's input).

4. Once the article is finalized, it will be scheduled for publication.

The estimated time for publication is approximately 6-18 months after finalization (may be shorter or longer).

 

Peer-Review Process

Cermin Dunia Kedokteran Journal uses the standard review process from OJS to manage the article review process. The Standard Review Process guides reviewers through each stage of the process, ensuring a complete review history for each submitted article, and utilizing automatic reminder notifications and standard recommendations for submitted articles (Accepted, Accepted with revisions, Submitted for review, Rejected, and See comments).

An editor first reviews the submitted article. The manuscript will be evaluated at an early stage to determine whether it is in line with the focus and scope of the journal and complies with general writing guidelines or requires improvement (read: Author Guidelines). Each manuscript that passes this stage will be checked for plagiarism before being reviewed by reviewers. One of the reviewers is appointed from another institution (national or international). This journal uses a double-blind review process, in which manuscripts are sent to reviewers anonymously. Reviewer comments are also sent anonymously to the corresponding author to take the necessary action and response. Decisions regarding revised articles will be evaluated at an editorial board meeting, and the final decision will be sent to the corresponding author.

The editor will send the article to the reviewer via the website or send it via email to access the journal's website to complete the review process. Reviewers access the website

 

Publication Frequency

Cermin Dunia Kedokteran since 2010 (Volume 37), published 8 (eight) times per year.

Cermin Dunia Kedokteran since 2012 (Volume 39), published 12 (twelve) times every year.

Cermin Dunia Kedokteransince 2016 (Volume 43), regularly published 12 (twelve) times per year online at www.cdkjournal.com based on OJS.

 

Publication Fees

Currently, submissions to CDK are subject to a publication fee (IDR Rp500,000,-), payable in advance, for systematic reviews, meta-analyses, evidence-based case reports, and case reports; however, primary research manuscripts that are eligible for publication are exempt from the publication fee.

Articles involving foreign authors (authors from abroad or Indonesian authors affiliated with institutions abroad) will be exempt from fees, regardless of whether they are the first, second, or subsequent authors.
 
Further information regarding payment will be provided after the manuscript has been submitted and passed the initial screening process.

 

Repository Policy

Cermin Dunia Kedokteran (CDK) Journal is an open access journal (i.e., they can be accessed free of charge on the Internet).

Articles Used
Only the publisher’s final version, which are post-peer review papers, are allowed to be used. The use of the final version of the author’s paper and the pre-peer review version are not permitted. Authors are permitted to deposit their paper in an institutional or other repository of their choice without violating the rules of multiple publication provisions.

 

Advertising Policy
Editorial materials will not be influenced by advertisements. The CDK journal does not carry advertisements, either in its articles or on its website.

 

For further information, please contact the CDK secretariat via 021-42873888 ext. 2025 or cdk@kalbe.co.id.